AHCL — Anlon Healthcare Income Statement
0.000.00%
Last trade - 00:00- IN₹7.15bn
- IN₹7.79bn
- IN₹1.20bn
- 24
- 16
- 59
- 20
Annual income statement for Anlon Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 571 | 1,129 | 666 | 1,203 |
| Cost of Revenue | ||||
| Gross Profit | 126 | 230 | 308 | 446 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 536 | 1,019 | 530 | 897 |
| Operating Profit | 35.8 | 109 | 136 | 306 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1.08 | 69.9 | 97.5 | 269 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1.08 | 58.2 | 96.6 | 205 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1.08 | 58.2 | 96.6 | 205 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1.08 | 58.2 | 96.6 | 205 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.02 | 1.09 | 1.82 | 3.86 |